[HTML][HTML] Global burden of medication non-adherence in chronic obstructive pulmonary disease (COPD) and asthma: a narrative review of the clinical and economic …

EM Jansen, SJ van de Hei, BJH Dierick… - Journal of thoracic …, 2021 - ncbi.nlm.nih.gov
Medication non-adherence to asthma and chronic obstructive pulmonary disease therapy
poses a significant burden for patients and societies. Non-adherence encompasses poor …

[HTML][HTML] Effectiveness and success factors of educational inhaler technique interventions in asthma & COPD patients: a systematic review

SL Klijn, M Hiligsmann, SMAA Evers… - NPJ primary care …, 2017 - nature.com
With the current wealth of new inhalers available and insurance policy driven inhaler
switching, the need for insights in optimal education on inhaler use is more evident than …

[HTML][HTML] Enhancing respiratory medication adherence: the role of health care professionals and cost-effectiveness considerations

JFM van Boven, D Ryan, MN Eakin… - The Journal of Allergy …, 2016 - Elsevier
Adherence to medication comprises a multiphased temporal process involving (1) initiation
of prescribed therapy,(2) implementation as prescribed, and (3) subsequent persistence …

Addressing the impact and unmet needs of nonadherence in asthma and chronic obstructive pulmonary disease: where do we go from here?

R Dekhuijzen, F Lavorini, OS Usmani… - The Journal of Allergy …, 2018 - Elsevier
Nonadherence to treatment, and its associated health and economic burden, is particularly
problematic in asthma and chronic obstructive pulmonary disease management because of …

[HTML][HTML] The 2023 GOLD report: updated guidelines for inhaled pharmacological therapy in patients with stable COPD

PD Terry, R Dhand - Pulmonary Therapy, 2023 - Springer
Over the past 22 years, annual GOLD Reports have documented important changes in
guidance and recommendations for uniformly treating patients with chronic obstructive …

[HTML][HTML] Long-term cost-effectiveness of digital inhaler adherence technologies in difficult-to-treat asthma

SJ van de Hei, CH Kim, PJ Honkoop, JK Sont… - The Journal of Allergy …, 2023 - Elsevier
Background Digital inhalers can monitor inhaler usage, support difficult-to-treat asthma
management, and inform step-up treatment decisions yet their economic value is unknown …

Using electronic monitoring devices to measure inhaler adherence: a practical guide for clinicians

AHY Chan, J Harrison, PN Black, EA Mitchell… - The Journal of Allergy …, 2015 - Elsevier
Use of electronic monitoring devices (EMDs) for inhalers is growing rapidly because of their
ability to provide objective and detailed adherence data to support clinical decision making …

[HTML][HTML] Cost-effectiveness of bronchial thermoplasty, omalizumab, and standard therapy for moderate-to-severe allergic asthma

Z Zafari, M Sadatsafavi, CA Marra, W Chen… - PLoS …, 2016 - journals.plos.org
Background Bronchial thermoplasty (BT) is a recently developed treatment for patients with
moderate-to-severe asthma. A few studies have suggested the clinical efficacy of this …

[HTML][HTML] 12-year adherence to inhaled corticosteroids in adult-onset asthma

I Vähätalo, P Ilmarinen, LE Tuomisto… - ERJ Open …, 2020 - Eur Respiratory Soc
Adherence to inhaled corticosteroids (ICS) has been suggested to be poor but long-term
follow-ups are lacking. The objective of the present study was to assess adherence to ICS …

Asthma impacts on workplace productivity in employed patients who are symptomatic despite background therapy: a multinational survey

K Gruffydd-Jones, M Thomas… - Journal of asthma …, 2019 - Taylor & Francis
Background: Asthma affects millions of people worldwide, with many patients experiencing
symptoms that affect their daily lives despite receiving long-term controller medication …